Kizoo

Investor type

VC

Founded

2000

AUM

$348 M

Location

Karlsruhe, Baden-Württemberg, Germany

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Series B

Region of investment

North America South America Europe Middle East Africa Asia Australia and others
Investor profile last updated: 16 August, 2026

Profile

Kizoo Technology Capital is a venture capital firm based in Karlsruhe, Germany, established in 2000. The firm specializes in investing in rejuvenation biotechnology startups, focusing on innovative technologies that aim to prevent and reverse age-related diseases. Kizoo provides mentoring, seed, and early-stage financing to entrepreneurial teams dedicated to addressing the aging process.

The company's investment portfolio includes startups developing therapies in neurodegeneration, cardiovascular health, stem cell rejuvenation, and mitochondrial therapies. Notable projects include drugs targeting molecular damage associated with aging and approaches to rejuvenate aged stem cells. Kizoo also offers strategic support, leveraging the founders' extensive experience in both tech and biotech sectors to help startups navigate early-stage development and scale their innovations.

Kizoo's primary clients are young startup teams in the rejuvenation biotech field, with a mission to make a significant global impact on extending healthy human lifespans. The firm combines financial investment with mentoring to accelerate the growth of pioneering companies in this transformative area.

Industry

Biotechnology Education Edtech Financial Services Fintech Food and Beverage Healthcare Services Internet and Web Services Medical Devices SaaS Software MedTech Life Sciences HealthTech

Contacts

Name
Title
Email
avatar
Michael Greve CEO
CEO
m•••@•••
avatar
Frank Schueler Managing Director
Managing Director
f•••@•••
Upgrade to see contacts
avatar
ZOKqYJi5TvlUScGg ZOKqYJi5TvlUScGg
ZOKqYJi5TvlUScGg
avatar
ZOKqYJi5TvlUScGg ZOKqYJi5TvlUScGg
ZOKqYJi5TvlUScGg
avatar
ZOKqYJi5TvlUScGg ZOKqYJi5TvlUScGg
ZOKqYJi5TvlUScGg
Investment-team contacts for Kizoo — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Kizoo

Kizoo is a venture capital firm. It backs companies at Series A, Seed and Series B, writing tickets of $10-50 m.
Kizoo is located in Karlsruhe, Baden-Württemberg, Germany.
Kizoo was founded in 2000.
Kizoo invests in companies and startups in Biotechnology, Education, Edtech, Financial Services, Fintech, Food and Beverage, Healthcare Services, Internet and Web Services, Medical Devices, SaaS, Software, MedTech, Life Sciences, HealthTech.
Kizoo invests in companies and startups in North America, South America, Europe, Middle East, Africa, Asia, Australia and others.
Kizoo invests in companies and startups at Series A, Seed, Series B.
Kizoo usually invests $10-50 m on average.
Kizoo has around $348m assets under management.
Kizoo can be reached through its website kizoo.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Kizoo — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Kizoo directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.